Vivanza Biosciences Limited (VIVANZA.BO)
INR 3.5
(-3.58%)
INR 3.5
(-3.58%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 19.38 Million INR | 95.97% |
| 2022 | 9.89 Million INR | 103.94% |
| 2021 | 4.85 Million INR | 26.26% |
| 2020 | 3.84 Million INR | 12283.69% |
| 2019 | 31.02 Thousand INR | -98.62% |
| 2018 | 2.25 Million INR | -69.87% |
| 2017 | 7.47 Million INR | 6064.73% |
| 2016 | -125.27 Thousand INR | 0.0% |
| 2015 | - INR | 0.0% |
| 2014 | - INR | 0.0% |
| 2013 | - INR | 0.0% |
| 2012 | - INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 1.45 Million INR | -76.54% |
| 2024 Q1 | 6.18 Million INR | 1451.31% |
| 2023 Q4 | -458 Thousand INR | -111.06% |
| 2023 Q2 | 3.69 Million INR | -45.97% |
| 2023 Q3 | 4.13 Million INR | 12.1% |
| 2023 FY | 14.21 Million INR | 43.65% |
| 2023 Q1 | 6.83 Million INR | 449.88% |
| 2022 Q4 | 1.24 Million INR | -79.1% |
| 2022 Q2 | 4.16 Million INR | 115.09% |
| 2022 FY | 9.89 Million INR | 103.94% |
| 2022 Q1 | 1.93 Million INR | 20.11% |
| 2022 Q3 | 5.94 Million INR | 42.89% |
| 2021 Q4 | 1.61 Million INR | -0.31% |
| 2021 Q1 | 455 Thousand INR | -39.41% |
| 2021 Q3 | 1.61 Million INR | 115.75% |
| 2021 FY | 4.85 Million INR | 26.26% |
| 2021 Q2 | 749 Thousand INR | 64.62% |
| 2020 Q4 | 751 Thousand INR | -72.04% |
| 2020 FY | 3.84 Million INR | 12283.69% |
| 2020 Q1 | 286 Thousand INR | -91.29% |
| 2020 Q2 | 2.27 Million INR | 695.45% |
| 2020 Q3 | 2.68 Million INR | 18.07% |
| 2019 Q4 | 3.28 Million INR | 240.09% |
| 2019 FY | 31.02 Thousand INR | -98.62% |
| 2019 Q3 | 965 Thousand INR | 196.02% |
| 2019 Q2 | -1 Million INR | -2333.33% |
| 2019 Q1 | 45 Thousand INR | -93.12% |
| 2018 Q3 | -570 Thousand INR | -213.32% |
| 2018 Q4 | 654.35 Thousand INR | 214.8% |
| 2018 Q2 | 503 Thousand INR | -79.29% |
| 2018 FY | 2.25 Million INR | -69.87% |
| 2018 Q1 | 2.42 Million INR | 21.22% |
| 2017 FY | 7.47 Million INR | 6064.73% |
| 2017 Q3 | 2.03 Million INR | 50.22% |
| 2017 Q4 | 2 Million INR | -1.48% |
| 2017 Q1 | 3.73 Million INR | 39.75% |
| 2017 Q2 | 1.35 Million INR | -63.7% |
| 2016 Q1 | - INR | 0.0% |
| 2016 Q3 | 626 Thousand INR | -21.06% |
| 2016 Q2 | 793 Thousand INR | 0.0% |
| 2016 Q4 | 2.66 Million INR | 326.37% |
| 2016 FY | -125.27 Thousand INR | 0.0% |
| 2015 Q2 | - INR | 0.0% |
| 2015 Q4 | - INR | 0.0% |
| 2015 FY | - INR | 0.0% |
| 2015 Q1 | - INR | 0.0% |
| 2015 Q3 | - INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2014 Q3 | - INR | 0.0% |
| 2014 Q2 | - INR | 0.0% |
| 2014 FY | - INR | 0.0% |
| 2014 Q4 | - INR | 0.0% |
| 2013 Q3 | - INR | 0.0% |
| 2013 Q2 | - INR | 0.0% |
| 2013 Q1 | - INR | 0.0% |
| 2013 Q4 | - INR | 0.0% |
| 2013 FY | - INR | 0.0% |
| 2012 FY | - INR | 0.0% |
| 2012 Q4 | - INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 3.14 Million INR | -517.373% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | 82.654% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | 82.53% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 90.665% |
| Sunil Healthcare Limited | 247.86 Million INR | 92.178% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -5.467% |
| MedPlus Health Services Limited | 12.33 Billion INR | 99.843% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 113.218% |
| Patidar Buildcon Limited | -26 Thousand INR | 74665.385% |
| Roopa Industries Limited | 72.95 Million INR | 73.425% |
| Smruthi Organics Limited | 324.76 Million INR | 94.03% |
| Trident Lifeline Limited | 119.08 Million INR | 83.72% |
| PANJON LTD. | 33.77 Million INR | 42.606% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 126.624% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | 86.29% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 208.855% |
| Anuh Pharma Limited | 1.6 Billion INR | 98.791% |
| Crestchem Limited | 51.53 Million INR | 62.383% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 360.823% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 94.415% |
| Tyche Industries Limited | 290.84 Million INR | 93.334% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 97.325% |
| Trimurthi Limited | 1.95 Million INR | -893.696% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 93.546% |
| Norris Medicines Limited | 29.36 Million INR | 33.973% |
| Zenlabs Ethica Limited | 147.75 Million INR | 86.879% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 95.631% |
| ANG Lifesciences India Limited | 232.73 Million INR | 91.67% |
| Parmax Pharma Limited | 99.31 Million INR | 80.48% |
| Veerhealth Care Limited | 49.57 Million INR | 60.893% |
| Deccan Health Care Limited | 221.57 Million INR | 91.25% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 94.641% |
| Makers Laboratories Limited | 308.54 Million INR | 93.717% |
| Lactose (India) Limited | 230.3 Million INR | 91.582% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 119.427% |
| Zenith Healthcare Limited | 46.17 Million INR | 58.013% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 90.718% |
| Bacil Pharma Limited | -19.95 Thousand INR | 97277.945% |
| PRAVEG LIMITED | 266.99 Million INR | 92.739% |
| Denis Chem Lab Limited | 596.24 Million INR | 96.748% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 98.651% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 98.251% |
| Colinz Laboratories Limited | 16.35 Million INR | -18.539% |
| Godavari Drugs Limited | 359.01 Million INR | 94.6% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 4875.123% |
| Zenotech Laboratories Limited | 337.19 Million INR | 94.251% |
| Panchsheel Organics Limited | 356.44 Million INR | 94.561% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 97.124% |
| Phaarmasia Limited | 38.89 Million INR | 50.149% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 98.384% |
| Medi-Caps Limited | 68.09 Million INR | 71.528% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 94.149% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 98.488% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 97.298% |
| Mercury Laboratories Limited | 279.39 Million INR | 93.061% |
| Gennex Laboratories Limited | 276.99 Million INR | 93.001% |
| BDH Industries Limited | 175.55 Million INR | 88.957% |
| Coral Laboratories Limited | 332.39 Million INR | 94.167% |
| Concord Drugs Limited | 116.7 Million INR | 83.388% |
| Bharat Parenterals Limited | 989.46 Million INR | 98.041% |
| Beryl Drugs Limited | 108.5 Million INR | 82.132% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -93.483% |
| Evoq Remedies Limited | 47.43 Million INR | 59.128% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 91.349% |
| Transchem Limited | -8.96 Million INR | 316.228% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | 50.214% |
| Parnax Lab Limited | 552.1 Million INR | 96.489% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | 70.631% |
| Kerala Ayurveda Limited | 447.69 Million INR | 95.67% |
| Cian Healthcare Limited | 113.16 Million INR | 82.869% |
| Trinity League India Limited | 1.23 Million INR | -1473.62% |
| Syschem (India) Limited | 569.04 Million INR | 96.593% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 147.618% |
| Natural Capsules Limited | 557.1 Million INR | 96.52% |
| Auro Laboratories Limited | 249.39 Million INR | 92.226% |